RESULTS OF THE COMBINED GENERAL MEETING ON APRIL 2, 2024
RESULTS OF THE COMBINED GENERAL MEETING ON APRIL 2, 2024
- RESULTS OF THE COMBINED GENERAL MEETING ON APRIL 2, 2024
RESULTS OF THE COMBINED GENERAL MEETING ON APRIL 2, 2024
Paris (France) and Cambridge (Massachusetts, USA), April 04, 2024 – 11:00pm CET – Biophytis SA (Nasdaq CM : BPTS, Euronext Growth Paris : ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, announces the approval of all the resolutions presented by the Company and falling within the remit of the Ordinary and Extraordinary General Meeting. - Thanks to the mobilization of shareholders, the Meeting could be held with a quorum of almost 30% of the shareholders present or represented.
- The resolutions, which notably included a renewal of the usual financial delegations granted to the Company, were all approved.
- The results of the votes are available on the Biophytis website in the "Investors / General Meetings" section.